leisure time -WSS

leisure time

author：leisure time 2025-10-01 18:23:38 - browse：15

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： FDA endorses new sterilization method for medical devices

leisure time

explore

WSS

Pumping milk in bathrooms at health conferences is common

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Some top drug companies are starting to take action on climate

Cardiologists urge adding sexual orientation, gender identity to health records

What will Novo Nordisk's VC do with its influx of cash?

Lawsuit highlights wrinkle for disputes over surprise medical bills

entertainment

leisure time

focus

Drug repurposing or repositioning? The language matters

Study points to new risk in gene therapy death of Terry Horgan

Alkermes shareholders re

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

CDC picks Alphabet's Verily for wasterwater surveillance contract

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Lawsuit highlights wrinkle for disputes over surprise medical bills

Hollywood unions extend contract negotiations for actors

Pumping milk in bathrooms at health conferences is common

explore

Future doctors need a strong humanities education

With Roe v Wade overturned, abortion providers work to adapt

Microsoft launches AI tool for clinical documentation through Epic

Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal

Maisha Meds is a PBM, but don't call it that

Health insurers' Q3 question: how much care are people getting?

leisure time

leisure time

explore

hotspot